
Vectura Group Plc - Product Pipeline Analysis, 2022 Update
Description
Summary
Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) and other ailments. It offers formulation development, pharmaceutical analysis, device platforms, process development & technical transfer, product manufacturing and regulatory services. It has partnership and license agreements with global biotechnology and pharmaceutical companies to develop a portfolio of drugs, including inhaled in-market products and inhaled generics. Vectura is headquartered in Chippenham, Wiltshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) and other ailments. It offers formulation development, pharmaceutical analysis, device platforms, process development & technical transfer, product manufacturing and regulatory services. It has partnership and license agreements with global biotechnology and pharmaceutical companies to develop a portfolio of drugs, including inhaled in-market products and inhaled generics. Vectura is headquartered in Chippenham, Wiltshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vectura Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
36 Pages
- Vectura Group Plc Company Overview
- Vectura Group Plc Company Snapshot
- Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- Vectura Group Plc – Pipeline Analysis Overview
- Business Description
- Vectura Group Plc - Key Facts
- Vectura Group Plc - Major Products and Services
- Vectura Group Plc Pipeline Products by Development Stage
- Vectura Group Plc Ongoing Clinical Trials by Trial Status
- Vectura Group Plc Pipeline Products Overview
- Digitally - Connected LOMI Device
- Digitally - Connected LOMI Device Product Overview
- Flutiform pMDI
- Flutiform pMDI Product Overview
- FOX Vibrating Mesh Nebulizer
- FOX Vibrating Mesh Nebulizer Product Overview
- MRX006 - Multidose Combined DPI Inhaler
- MRX006 - Multidose Combined DPI Inhaler Product Overview
- SKP-2075
- SKP-2075 Product Overview
- VR475 Combination Device
- VR475 Combination Device Product Overview
- VR647
- VR647 Product Overview
- VR647 Clinical Trial
- Vectura Group Plc - Key Competitors
- Vectura Group Plc - Key Employees
- Vectura Group Plc - Key Employee Biographies
- Vectura Group Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Vectura Group Plc, Recent Developments
- Jun 10, 2021: Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production
- May 27, 2021: Vectura Group announce Directorate Change
- Apr 23, 2021: Vectura Group announce 2020 Annual Report, 2021 AGM notice & GM circular
- Mar 18, 2021: Vectura Group Announces 2020 Preliminary Results
- Jan 12, 2021: Vectura Group: Trading update
- Apr 17, 2020: Vectura presents latest science at Digital RDD 2020
- Nov 27, 2019: VR315US: Hikma submits response to FDA
- Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
- Oct 22, 2019: Vectura to present latest science at Drug Delivery to the Lungs (DDL) 2019
- Oct 04, 2019: UK court dismisses GSK's claims of passing off in respect of Sandoz's AirFluSal Forspiro
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Vectura Group Plc Pipeline Products by Equipment Type
- Table 3: Vectura Group Plc Pipeline Products by Indication
- Table 4: Vectura Group Plc, Key Facts
- Table 5: Vectura Group Plc, Major Products and Services
- Table 6: Vectura Group Plc Number of Pipeline Products by Development Stage
- Table 7: Vectura Group Plc Pipeline Products Summary by Development Stage
- Table 8: Vectura Group Plc Ongoing Clinical Trials by Trial Status
- Table 9: Vectura Group Plc Ongoing Clinical Trials Summary
- Table 10: Digitally - Connected LOMI Device - Product Status
- Table 11: Digitally - Connected LOMI Device - Product Description
- Table 12: Flutiform pMDI - Product Status
- Table 13: Flutiform pMDI - Product Description
- Table 14: FOX Vibrating Mesh Nebulizer - Product Status
- Table 15: FOX Vibrating Mesh Nebulizer - Product Description
- Table 16: MRX006 - Multidose Combined DPI Inhaler - Product Status
- Table 17: MRX006 - Multidose Combined DPI Inhaler - Product Description
- Table 18: SKP-2075 - Product Status
- Table 19: SKP-2075 - Product Description
- Table 20: VR475 Combination Device - Product Status
- Table 21: VR475 Combination Device - Product Description
- Table 22: VR647 - Product Status
- Table 23: VR647 - Product Description
- Table 24: VR647 - A Phase I Clinical Study of VR-647
- Table 25: VR647 - A Phase I Clinical Study of VR-647 in Adult Asthma Subjects
- Table 26: VR647 - Phase II Pharmacokinetic Study of VR-647 in Children
- Table 27: VR647 - Phase III Study of VR-647
- Table 28: Vectura Group Plc, Key Employees
- Table 29: Vectura Group Plc, Key Employee Biographies
- Table 30: Vectura Group Plc, Other Locations
- Table 31: Vectura Group Plc, Subsidiaries
- Table 32: Glossary
- List of Figures
- Figure 1: Vectura Group Plc Pipeline Products by Equipment Type
- Figure 2: Vectura Group Plc Pipeline Products by Development Stage
- Figure 3: Vectura Group Plc Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.